Mechanisms and therapeutic applications of immune stimulatory CpG DNA

Pharmacology and Therapeutics

Volumn 84, Issue 2, 1999, Pages 113-120

  Krieg, Arthur M ^a,b,c   Yi, Ae Kyung ^a   Hartmann, Gunther ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CpG ImmunoPharmaceuticals   (United States)

Author keywords

B cell; Dendritic cell; Immunotherapy; Lymphocyte activation; Vaccine

Indexed keywords

ADJUVANT; CANCER VACCINE; CYTOKINE; DINUCLEOTIDE; DNA VACCINE; OLIGODEOXYNUCLEOTIDE;

ALLERGIC DISEASE; APOPTOSIS; B LYMPHOCYTE ACTIVATION; CANCER; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; DENDRITIC CELL; GENE THERAPY; HUMAN; IMMUNOSTIMULATION; IMMUNOTHERAPY; INFECTION; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CPG ISLANDS; DNA; HUMANS; IMMUNITY, CELLULAR;

EID: 0032867015     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00023-6     Document Type: Review

References (64)

1. Anitescu M., Chace J.H., Tuetken R., Yi A.-K., Berg D.J., Krieg A.M., Cowdery J.S. Interleukin-10 functions in vitro and in vivo to inhibit bacterial DNA-induced secretion of interleukin-12. J Interferon Cytokine Res. 17:1997;781-788.
2. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol. 157:1996;1840-1845.
3. Bendigs S., Salzer U., Lipford G.B., Wagner H., Heeg K. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur J Immunol. 29:1999;1209-1218.
4. Bennett R.M., Gabor G.T., Merritt M.M. DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. J Clin Invest. 76:1985;2182-2190.
5. Bird A.P. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:1987;342-347.
6. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol. 84:1997;185-193.
7. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on Th1 immunity. J Exp Med. 186:1997;1623-1631.
8. Cowdery J.S., Chace J.H., Yi A.-K., Krieg A.M. Bacterial DNA induces NK cells to produce interferon-γ in vivo and increases the toxicity of lipopolysaccharides. J Immunol. 156:1996;4570-4575.
9. Crooke R.M., Crooke S.T., Graham M.J., Cooke M.E. Effect of antisense oligonucleotides on cytokine release from human keratinocytes in an in vitro model of skin. Toxicol Appl Pharmacol. 140:1996;85-93.
10. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent adjuvant in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 160:1998;870-876.
11. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol. 162:1999;2291-2298.
12. Ewel C.H., Urba S.J., Kopp W.C., Smith J.W. II, Steis R.G., Rossio J.L., Longo D.L., Jones M.J., Alvord W.G., Pinsky C.M., Beveridge J.M., McNitt K.L., Creekmore S.P. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer. clinical and immunological effects Cancer Res. 52:1992;3005-3010.
13. Gilkeson G.S., Pippen A.M.M., Pisetsky D.S. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest. 95:1995;1398-1402.
14. Gilkeson G.S., Ruiz P., Pippen A.M.M., Alexander A.L., Lefkowith J.B., Pisetsky D.S. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med. 183:1996;1389-1397.
15. Hartmann, G., & Krieg, A. M. (1999) CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther, in press.
16. Hartmann G., Krug A., Waller-Fontaine K., Endres S. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor. dependence on phosphorothioate modification and reversal by heparin Mol Med. 2:1996;429-438.
17. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides. a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA J Immunol. 161(6):1998;3042-3049.
18. Jones, T. R., Obaldia, N., III, Gramzinski, R. A., Charoenvit, Y., Kolodny, N., Davis, H. L., Krieg, A. M., & Hoffman, S. L. (1999). Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine, in press.
19. Kline J.N., Businga T.R., Waldschmidt T.J., Weinstock J.V., Krieg A.M. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol. 160:1998;2555-2559.
20. Klinman D., Yi A.-K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN. Proc Natl Acad Sci USA. 93:1996;2879-2883.
21. Krieg A.M. Uptake and localization of phosphodiester and chimeric oligodeoxynucleotides in normal and leukemic primary cells. Akhtar S. Delivery Strategies for Antisense Oligonucleotide Therapeutics. 1995;177-190 CRC Press, New York. a.
22. Krieg A.M. Cpg dna. a pathogenic factor in systemic lupus erythematosus? J Clin Immunol. 15:1995;284-292. b.
23. Krieg A., Tonkinson J., Matson S., Zhao Q., Saxon M., Zhang L.-M., Bhanja U., Yakubov L., Stein C.A. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acad Sci USA. 90:1993;1048-1052.
24. Krieg A.K., Yi A.-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G., Klinman D. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
25. Krieg A.M., Love-Homan L., Yi A.-K., Harty J.T. CpG DNA induces a sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol. 161:1998;2428-2434. a.
26. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Zhang L., Yang L., Yi A.K., Short D., Davis H. Sequence motifs in adenoviral DNA which block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA. 95:1998;12631-12636. b.
27. Krown S.E. Interferons and interferon inducers in cancer treatment. Semin Oncol. 13:1986;207-217.
28. Lipford G.B., Sparwasser T., Bauer M., Zimmermann S., Koch E.-S., Heeg K., Wagner H. Immunostimulatory DNA. sequence-dependent production of potentially harmful or useful cytokines Eur J Immunol. 27:1997;3420-3426.
29. Loke S.L., Stein C.A., Zhang X.H., Mori K., Nakanishi M., Subasinghe C., Cohen J.S., Neckers L.M. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA. 86:1989;3474-3478.
30. MacFarlane D.E., Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucletides by quinacrine, chloroquine, and structurally related compounds. J Immunol. 160:1998;1122-1131.
31. MacFarlane D.E., Manzel L., Krieg A.M. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents. evidence for blockade of apoptosis at a distal signalling step Immunology. 91:1997;586-593.
32. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 147:1991;1759-1764.
33. Messina J.P., Gilkeson G.S., Pisetsky D.S. The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell Immunol. 147:1993;148-157.
34. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel adjuvant for systemic and mucosal immunization with influenza virus. Vaccine. 16:1998;1216-1224.
35. Mor G., Singla M., Steinberg A.D., Hoffman S.L., Okuda K., Klinman D.M. Do DNA vaccines induce autoimmune disease? Hum Gene Ther. 8:1997;293-300.
36. Redford T.W., Yi A.-K., Ward C.T., Krieg A.M. Cyclosporine A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J Immunol. 161(8):1998;3930-3935.
37. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.-D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3:1997;849-854.
38. Schwartz D., Quinn T.J., Thorne P.S., Sayeed S., Yi A.-K., Krieg A.M. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest. 100:1997;68-73.
39. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heet K., Wagner H. Bacterial DNA causes septic shock. Nature. 386:1997;336-337. a.
40. Sparwasser T., Miethe T., Lipford G., Erdmann A., Hacker H., Heeg K., Wagner H. Macrophages sense pathogens via DNA motifs. induction of tumor necrosis factor-α-mediated shock Eur J Immunol. 27:1997;1671-1679. b.
41. Stacey K.J., Sweet M.J., Hume D.A. Macrophages ingest and are activated by bacterial DNA. J Immunol. 157:1996;2116-2122.
42. Sun S., Beard C., Jaenisch R., Jones P., Sprent J. Mitogenicity of DNA from different organisms for murine B cells. J Immunol. 159:1997;3119-3125.
43. Talmadge J.E., Adams J., Phillips H., Collins M., Lenz B., Schneider M., Schlick E., Ruffmann R., Wiltrout R.H., Chirigos M.A. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Cancer Res. 45:1985;1058-1065.
44. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., Furutani Y., Yano O., Kataoka T., Sudo T., Makiguchi N., Suganuma T. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis GCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst. 72:1984;955-962.
45. Tokunaga T., Yamamoto S., Namba K. A synthetic single-stranded DNA, poly(dG,dC), induces interferon-α/β and -γ, augments natural killer activity, and suppresses tumor growth. Jpn J Cancer Res. 79:1988;682-686.
46. Tonkinson J.L., Stein C.A. Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22:1994;4268-4275.
47. Tuetken R.S., Yi A.-K., Krieg A.M. The immune effects of bacterial DNA and their possible role in the aathogenesis of lupus. Tsokos G.C., Kammer G. Lupus. Molecular and Cellular Pathogenesis:1999;79-100 Humana Press, Totowa.
48. Wang Z., Karras J.G., Colarusso T.P., Foote L.C., Rothstein T.L. Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis. Cell Immunol. 180:1997;162-167.
49. Weiner G.J., Liu H.-M., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA. 94:1997;10833-10837.
50. Wiltrout R.H., Salup R.R., Twilley T.A., Talmadge J.E. Immunomodulation of natural killer activity by polyribonucleotides. J Biol Response Modif. 4:1985;512-517.
51. Wooldridge J.E., Ballas Z., Krieg A.M., Weiner G.J. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood. 89:1997;2994-2998.
52. Yakubov L.A., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko L.V., Vlassov V.V. Mechanism of oligonucleotide uptake by cells. involvement of specific receptors? Proc Natl Acad Sci USA. 86:1989;6454-6458.
53. Yamamoto S., Kuramoto E., Shimada S., Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res. 79:1988;866-873.
54. Yamamoto S., Yamamoto T., Kataoka T., Kuramoto E., Yano O., Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J Immunol. 148:1992;4072-4076. a.
55. Yamamoto S., Yamamoto T., Shimada S., Kuramoto E., Yano O., Kataoka T., Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol. 36:1992;983-997. b.
56. Yew N.S., Wang K.X., Przybylska M., Bagley R.G., Stedman M., Marshall J., Scheule R.K., Cheng S.H. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum Gene Ther. 10:1999;223-234.
57. Yi A.-K., Krieg A.M. CpG DNA rescue from anti-IgM induced WEHI-231 B lymphoma apoptosis via modulation of IκBα and IκBβ and sustained activation of nuclear factor-κB/c-Rel. J Immunol. 160:1998;1240-1245. a.
58. Yi A.-K., Krieg A.M. Rapid induction of mitogen activated protein kinases by immune stimulatory CpG DNA. J Immunol. 161:1998;4493-4497. b.
59. Yi A.-K., Chace J.H., Cowdery J.S., Krieg A.M. IFN-γ promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol. 156:1996;558-564. a.
60. Yi A.-K., Hornbeck P., Lafrenz D.E., Krieg A.M. CpG DNA rescue of murine B lymphoma cells from anti-IgM induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-XL. J Immunol. 157:1996;4918-4925. b.
61. Yi A.-K., Klinman D.M., Martin T.L., Matson S., Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA. systemic induction of IL-6 transcription through an antioxidant-sensitive pathway J Immunol. 157:1996;5394-5402. c.
62. Yi A.-K., Chang M., Peckham D.W., Krieg A.M., Ashman R.F. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol. 160:1998;5898-5906. a.
63. Yi A.-K., Tuetken R., Redford T., Kirsch J., Krieg A.M. CpG motifs in bacterial DNA activates leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol. 160:1998;4755-4761. b.
64. Zimmerman S., Egeter O., Hausmann S., Lipford G.B., Rocken M., Wagner H., Geeg K. Cutting edge. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine Leishmaniasis J Immunol. 160:1998;3627-3630.